Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-09-009519
Filing Date
2009-02-18
Accepted
2009-02-18 11:05:19
Documents
1
Period of Report
2009-02-09

Document Format Files

Seq Description Document Type Size
1 v140619_ex.html 4  
1 v140619_ex.xml 4 3755
  Complete submission text file 0001144204-09-009519.txt   5488
Mailing Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
NEXMED INC (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address NEXMED 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
EMIL ARTHUR D (Reporting) CIK: 0001245157 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 09617618